MFS
KDNY

MSI Financial Services’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

MSI Financial Services’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-60
Closed -$8K – 4131
2015
Q4 		$8K Buy
+60
New +$8.15K ﹤0.01% 2852

Other funds holding KDNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

MSI Financial Services's KDNY Position: Q1 2016 in Review

MSI Financial Services sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q1 2016, closing a stake of 60 shares — an estimated $8K sold.

MSI Financial Services first reported a position in KDNY in Q4 2015 and held it in 1 quarter. The position peaked at $8K in Q4 2015. 89 funds tracked by Wall St. Rank hold KDNY as of Q1 2016.

  • MSI Financial Services reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • MSI Financial Services sold 60 Chinook Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $8K.
  • MSI Financial Services first reported a position in Chinook Therapeutics, Inc. Common Stock in Q4 2015 and held it in 1 quarter.
  • MSI Financial Services's Chinook Therapeutics, Inc. Common Stock position peaked at $8K in Q4 2015.
  • 89 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q1 2016.

Based on MSI Financial Services's 13F filing for Q1 2016, filed 22 Apr 2016.